Calla, N. E. Q., Miguel, R. D. V., Boyaka, P. N., Hall-Stoodley, L., Kaur, B., Trout, W., . . . Cherpes, T. L. (2016). Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. Mucosal Immunol.
Citação norma ChicagoCalla, Nirk E Quispe, Rodolfo D Vicetti Miguel, Prosper N. Boyaka, Luanne Hall-Stoodley, Balveen Kaur, Wayne Trout, Stephen D. Pavelko, and Thomas L. Cherpes. "Medroxyprogesterone Acetate and Levonorgestrel Increase Genital Mucosal Permeability and Enhance Susceptibility to Genital Herpes Simplex Virus Type 2 Infection." Mucosal Immunol 2016.
Citação norma MLACalla, Nirk E Quispe, et al. "Medroxyprogesterone Acetate and Levonorgestrel Increase Genital Mucosal Permeability and Enhance Susceptibility to Genital Herpes Simplex Virus Type 2 Infection." Mucosal Immunol 2016.